Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
12:22:18 EDT Wed 01 May 2024
Enter Symbol
or Name
USA
CA



Q:ONCY - ONCOLYTICS BIOTECH INC - http://www.oncolyticsbiotech.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ONCY - Q5.31.11·1.1214.91.12+0.010.999.51022281.08  1.1201  1.083.3942  0.88311:58:32Apr 3015 min RT 2¢

Recent Trades - Last 10 of 228
Time ETExPriceChangeVolume
11:58:32Q1.11 78
11:54:18Q1.120.01300
11:48:41Q1.11 2,094
11:47:30Q1.11990.0099100
11:47:30Q1.120.01100
11:42:36Q1.1150.0051
11:36:01Q1.11 45
11:34:47Q1.11990.0099200
11:30:52Q1.1150.005200
11:30:52Q1.11980.00982,600

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-30 07:00U:ONCYNews ReleaseOncolytics Biotech(TM) to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights
2024-04-25 07:00U:ONCYNews ReleaseOncolytics Biotech(TM) Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting
2024-04-11 07:00U:ONCYNews ReleaseOncolytics Biotech(TM) Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
2024-04-02 07:00U:ONCYNews ReleaseOncolytics Biotech(TM) to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference
2024-03-07 16:01U:ONCYNews ReleaseOncolytics Biotech(TM) Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
2024-03-05 08:30U:ONCYNews ReleaseIncreasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
2024-03-05 07:00U:ONCYNews ReleaseOncolytics Biotech(TM) Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN
2024-03-04 07:00U:ONCYNews ReleaseOncolytics Biotech(TM) to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights
2024-02-28 07:00U:ONCYNews ReleaseOncolytics Biotech(TM) Announces Presentation at the Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference
2024-02-14 08:30U:ONCYNews ReleaseAnal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies
2024-02-14 07:00U:ONCYNews ReleaseOncolytics Biotech ® Initiates Enrollment Expansion of GOBLET Anal Cancer Cohort
2024-02-14 07:00U:ONCYNews ReleaseOncolytics Biotech ‚ ® Initiates Enrollment Expansion of GOBLET Anal Cancer Cohort